Autonomous train technology is advancing rapidly, with European startup Futurail securing €7.5M and US company Parallel Systems launching commercial pilots. These innovations could solve critical labor shortages while revolutionizing logistics efficiency.
Scientists have discovered that lipid nanoparticles, crucial carriers for modern medicines, possess surprisingly varied internal architectures. These structural differences directly influence how effectively therapies reach their cellular destinations, according to new research.
Lipid nanoparticles (LNPs), the delivery vehicles behind groundbreaking COVID-19 vaccines and gene therapies, are far more structurally diverse than previously assumed, according to reports from a multi-institutional research collaboration. The findings, published in Nature Biotechnology, reveal that these microscopic carriers come in varied configurations that significantly impact their therapeutic performance.
The autonomous vehicle industry is entering a new phase of commercial deployment as Waymo reignites its delivery ambitions through a…
